Theseus Pharmaceuticals, Inc. (THRX) [Rocket]

Overview

Theseus Pharmaceuticals, Inc. (THRX)

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
08/10/2023	SC 13G/A	FMR LLC reports a 0% stake in THESEUS PHARMACEUTICALS INC
08/10/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/10/2023	8-K	Quarterly results
07/19/2023	4	GORDON CARL L (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.
07/19/2023	4	Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/19/2023	4	Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
Revenues	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0
Research and development	35.7	18.3	6.0
General and administrative	18.4	9.0	0.9
EBIT	-54.1	-27.3	-6.8
Pre-tax income	-50.6	-27.3	-12.0
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-50.6	-27.3	-12.0

Diluted EPS	($1.31)	($2.84)	($21.10)
Shares outstanding (diluted)	38.5	9.6	0.6

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy